121 related articles for article (PubMed ID: 31499585)
1. Proteomic characterization of arsenic and cadmium exposure in bladder cells.
Chen YT; Ou Yang WT; Juang HH; Chen CL; Chen HW; Tsui KH; Chang YH; Tsai CH; Hsueh C; Liao WC
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8578. PubMed ID: 31499585
[TBL] [Abstract][Full Text] [Related]
2. Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.
Wu TF; Hsu LT; Tsang BX; Huang LC; Shih WY; Chen LY
BMC Complement Altern Med; 2016 Mar; 16():96. PubMed ID: 26955879
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
Lee H; Kim K; Woo J; Park J; Kim H; Lee KE; Kim H; Kim Y; Moon KC; Kim JY; Park IA; Shim BB; Moon JH; Han D; Ryu HS
Mol Cell Proteomics; 2018 Sep; 17(9):1788-1802. PubMed ID: 29950347
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Evaluation of Heavy Metals and Trace Elements in the Urinary Bladder: Comparison Between Cancerous, Adjacent Non-cancerous and Normal Cadaveric Tissue.
Abdel-Gawad M; Elsobky E; Shalaby MM; Abd-Elhameed M; Abdel-Rahim M; Ali-El-Dein B
Biol Trace Elem Res; 2016 Dec; 174(2):280-286. PubMed ID: 27147435
[TBL] [Abstract][Full Text] [Related]
5. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
[TBL] [Abstract][Full Text] [Related]
6. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase induction in arsenic-exposed rat bladder epithelium.
Huang YC; Yu HS; Chai CY
Exp Toxicol Pathol; 2016 Jan; 68(1):61-8. PubMed ID: 26482281
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of an environmental isolate of Rhodotorula mucilaginosa after arsenic and cadmium challenge: Identification of a protein expression signature for heavy metal exposure.
Ilyas S; Rehman A; Coelho AV; Sheehan D
J Proteomics; 2016 Jun; 141():47-56. PubMed ID: 27090762
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma.
Li CF; Shen KH; Chien LH; Huang CH; Wu TF; He HL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671787
[TBL] [Abstract][Full Text] [Related]
10. Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
Michailidi C; Hayashi M; Datta S; Sen T; Zenner K; Oladeru O; Brait M; Izumchenko E; Baras A; VandenBussche C; Argos M; Bivalacqua TJ; Ahsan H; Hahn NM; Netto GJ; Sidransky D; Hoque MO
Cancer Prev Res (Phila); 2015 Mar; 8(3):208-21. PubMed ID: 25586904
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.
Makridakis M; Gagos S; Petrolekas A; Roubelakis MG; Bitsika V; Stravodimos K; Pavlakis K; Anagnou NP; Coleman J; Vlahou A
Proteomics; 2009 Jan; 9(2):287-98. PubMed ID: 19105184
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
Jou YC; Wang SC; Dai YC; Chen SY; Shen CH; Lee YR; Chen LC; Liu YW
Oncol Rep; 2019 Sep; 42(3):1005-1016. PubMed ID: 31322264
[TBL] [Abstract][Full Text] [Related]
13. Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics.
Chen SH; Wang YW; Hsu JL; Chang HY; Wang CY; Shen PT; Chiang CW; Chuang JJ; Tsai HW; Gu PW; Chang FC; Liu HS; Chow NH
Toxicol Appl Pharmacol; 2010 Jan; 242(2):126-35. PubMed ID: 19818359
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.
Yang MH; Chu PY; Chen SC; Chung TW; Chen WC; Tan LB; Kan WC; Wang HY; Su SB; Tyan YC
Biochem Biophys Res Commun; 2011 Aug; 411(4):714-20. PubMed ID: 21782798
[TBL] [Abstract][Full Text] [Related]
15. Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
Chang CH; Liu CS; Liu HJ; Huang CP; Huang CY; Hsu HT; Liou SH; Chung CJ
Int J Urol; 2016 Mar; 23(3):233-9. PubMed ID: 26663353
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.
Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF
Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780
[TBL] [Abstract][Full Text] [Related]
17. Chronic Arsenic Exposure Upregulates the Expression of Basal Transcriptional Factors and Increases Invasiveness of the Non-Muscle Invasive Papillary Bladder Cancer Line RT4.
Mehus AA; Bergum N; Knutson P; Shrestha S; Kalonick M; Zhou X; Garrett SH; Sens DA; Sens MA; Somji S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293167
[TBL] [Abstract][Full Text] [Related]
18. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
[TBL] [Abstract][Full Text] [Related]
19. Cadmium in blood of Tunisian men and risk of bladder cancer: interactions with arsenic exposure and smoking.
Feki-Tounsi M; Olmedo P; Gil F; Khlifi R; Mhiri MN; Rebai A; Hamza-Chaffai A
Environ Sci Pollut Res Int; 2013 Oct; 20(10):7204-13. PubMed ID: 23673919
[TBL] [Abstract][Full Text] [Related]
20. Selective Cytotoxicity and Changes in Protein Expression of T24 Bladder Carcinoma Permanent Cell Line after Treatment with Hemocyanins.
Dolashki A; Antonova O; Velkova L; Kaynarov D; Voelter W; Dolashka P
Curr Med Chem; 2022; 29(42):6479-6498. PubMed ID: 35993464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
